Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation.
about
Mechanisms and potential therapeutic applications of microglial activation after brain injuryAlzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and GammaGlitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma.PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteinsCyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users.Microglia activation and anti-inflammatory regulation in Alzheimer's diseasePPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.Effects of peroxisome proliferator-activated receptor alpha/delta agonists on HDL-cholesterol in vervet monkeys.Involvement of PPAR nuclear receptors in tissue injury and wound repairPPARγ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genesPPARγ Is Activated during Congenital Cytomegalovirus Infection and Inhibits Neuronogenesis from Human Neural Stem Cells.Endothelial cells and astrocytes: a concerto en duo in ischemic pathophysiology.Protective effect of pioglitazone on morphine-induced neuroinflammation in the rat lumbar spinal cord.Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.PPAR-gamma Pro12Ala genotype and risk of cognitive decline in eldersPeroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia.Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation.S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2)The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-gamma AgonistsThe PPAR-gamma Agonist 15-Deoxy-Delta-Prostaglandin J(2) Attenuates Microglial Production of IL-12 Family Cytokines: Potential Relevance to Alzheimer's Disease.RAR/RXR and PPAR/RXR Signaling in Spinal Cord Injury.Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages.Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's Disease.Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis.Protective Effect of PPARγ Agonists on Cerebellar Tissues Oxidative Damage in Hypothyroid Rats.Novel findings in drug-induced dendritic cell tolerogenicity.Anti-neuroinflammatory agents for the treatment of Alzheimer's disease.The role of neuroinflammation in dementias.PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney.PPARs in Alzheimer's Disease.Impact and Therapeutic Potential of PPARs in Alzheimer's Disease.Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients.Effects of Wy14643 on hepatic ischemia reperfusion injury in rats.PPARs: a new target for neuroprotection.
P2860
Q26864358-BB68F3A6-411B-4EF0-9A04-3408AEED65AFQ28075617-B3ABFA62-4078-4858-9802-8B83CB7916A0Q33196298-0741CB2D-3CD4-4DEE-A120-923FD3850EA7Q33573305-1B0BF134-8582-4384-9A89-08E656FB383FQ33595538-4E26932F-7BE4-4A3A-BA06-BF2C082ACD71Q33644063-83BBB0F9-8E6A-4D3D-8935-B4EDE0552E2DQ33674869-C84A2BC7-A5A3-4C48-8B7E-40611A5E7728Q33727021-B5370717-CC8D-4EC0-9E33-3D9EB23984CFQ33943873-D8A41ABC-9C08-4D93-88EC-54D44EF4955AQ34143718-7808A9DC-713D-4734-B27F-F39C01235161Q34395356-ED21E967-A021-4D67-957B-F3B2BC9D71B4Q34416422-F2D5FDCE-D63D-4F6C-8BAB-1E47673F3EE0Q34491511-377F3CF4-43A5-4592-8B1E-093101590602Q35990083-DF5B6DDF-11DC-4889-8EE0-FB3ADD1151D7Q36072867-75E2D206-10D2-4927-A972-C566DEB2B0A7Q36086121-8A0965A1-F1D6-415D-A9AE-6E63718C79CDQ36148455-DD3C1CEA-A4A0-46C1-BA53-42725858FD95Q36445372-F18D5ECA-94F2-47F4-8441-72E68D0330FFQ36528985-7DF80201-0950-49E4-B8BE-6CE2E91A7DDCQ36607332-31C64A55-E44D-4376-885D-198108A88C20Q36631061-E01F323B-0CBE-4CAB-9675-AC05E2AE2F9CQ36676619-DCF6D2A5-1E2B-45D8-B4A8-99756633BA6FQ36712237-F52F7DCF-9516-4596-9F46-7EC2E5DEBA14Q36731548-CD9864E6-D4C6-4043-A444-CD93C8D4DECBQ36742787-0E9CD700-09D8-4DB5-9F1D-811F8BB5C381Q37024759-BA0A62B6-2EA8-452A-91AF-B54904781D34Q37096952-1087270F-0836-43BD-859B-A823AE36AE4EQ37157528-51E5B223-EF8E-4E07-8A47-F8E44C85B1BDQ37157531-CE7491FA-70BE-4CBF-8CFC-75DC01481B4FQ37208433-84527B47-F89D-4B20-8ADF-98A74DB7792BQ37571681-A45E853D-19BE-442B-A02C-63A8CABC8E37Q37809070-755C4B78-20D1-4F6B-A02F-9F31E1D747E7Q38136313-00220CA4-48E9-40F2-872F-0B06742763F8Q38365247-7F042D5C-594E-411E-A730-6BB2CCEB5966Q39451549-43460E5E-E30B-4543-98B6-94605DEC63DDQ40288794-CC9F766C-5E2C-422A-8AB8-3CF68269FEA6Q40576825-0F8C9546-4F33-40E0-A0C8-B8E8D7C52D3DQ40610269-36218B45-75CB-410E-9BDE-956FBB067659Q42619953-B8BE6C44-3A6F-41F3-8B1D-E227BACA99D2Q42718625-A758F628-A3EA-4FB0-B478-3DA004775E66
P2860
Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Effects of peroxisome prolifer ...... l nervous system inflammation.
@en
type
label
Effects of peroxisome prolifer ...... l nervous system inflammation.
@en
prefLabel
Effects of peroxisome prolifer ...... l nervous system inflammation.
@en
P2860
P356
P1476
Effects of peroxisome prolifer ...... l nervous system inflammation.
@en
P2093
Paul D Drew
Tammy Kielian
P2860
P304
P356
10.1002/JNR.10501
P577
2003-02-01T00:00:00Z